Form 4 for BSEM BioStem Technologies, Inc.
Accepted 2026-09-17 16:30:16 ET · period of report 2026-09-15 · accession 0001193125-26-394397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-17 16:30 | 2026-09-15 | BSEM | POE BRANDON | CFO | M - OptEx | $0.00 | +1,694 | 58.1K | +3% | $0 |
| D | 2026-09-17 16:30 | 2026-09-15 | BSEM | POE BRANDON | CFO | M - OptEx | $0.00 | -1,694 | 6,775 | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | M | A | 1,694 | $0.00 | 58,062 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-09-15 | M | D | 1,694 | $0.00 | 6,775 | D | — · — to — | 1,694 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F4) These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024). (F4) These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024). |